Lexaria Bioscience Corp. (OTCMKTS:LXRP – Get Free Report)’s stock price passed above its 50-day moving average during trading on Monday . The stock has a 50-day moving average of $0.22 and traded as high as $0.25. Lexaria Bioscience shares last traded at $0.22, with a volume of 2,151,500 shares trading hands.
Lexaria Bioscience Stock Down 10.7 %
The company has a quick ratio of 8.01, a current ratio of 8.52 and a debt-to-equity ratio of 0.01. The stock’s 50 day simple moving average is $0.22.
Lexaria Bioscience Company Profile
Lexaria Bioscience Corp. operates in the drug delivery platform business. It develops and out-licenses its DehydraTECH technology for the delivery of bioactive compounds that promotes healthy ingestion methods, lower overall dosing, and higher effectiveness in active molecule delivery. The company has licensed DehydraTECH to various companies operating in the nicotine, pharmaceutical, nutraceutical, and vitamin industries.
See Also
- Five stocks we like better than Lexaria Bioscience
- 2 Fintech Stocks to Buy Now and 1 to Avoid
- TJX Stock: A Buying Opportunity Before the Holiday Rush
- Comparing and Trading High PE Ratio Stocks
- Micron’s Blowout Results Pave the Way for Seagate’s Stock Surge
- Why Special Dividends Can be a Delightful Surprise for Income Investors
- Zeta Global’s AI Cloud: Your Secret Weapon for Massive Growth
Receive News & Ratings for Lexaria Bioscience Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lexaria Bioscience and related companies with MarketBeat.com's FREE daily email newsletter.